Wikipedia -WSS

Wikipedia

author：fashion 2025-08-12 11:29:29 - browse：23214

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： What PEPFAR has meant on the ground in Ukraine

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Study: Adult vaccinations pay for themselves in societal benefits

Radiology is caught between AI's potential and concern for patients

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Brain worms: The science behind RFK Jr.'s parasitic infection

Steward Health Care files for bankruptcy

explore

Wikipedia

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

After gene therapy, two congenitally deaf children hear for the first time

Novavax promises a turnaround & Lilly roils the obesity market

Medicare says breakthrough device reimbursement rule to come by summer

Medical leaders decry Supreme Court decision on affirmative action

STAT letters to the editor on burnt

Heart attack and stroke risk calculators need revising

How to improve immunocompromised access to mAb treatments

In Memoriam: Notable people who died in 2023

Congenital heart disease patients face new threat of heart failure

hotspot

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

H5N1 bird flu: what we're starting to learn about infection in cows

H5N1 bird flu: what we're starting to learn about infection in cows

Software glitch causes Tandem insulin pump to shutdown, FDA warns

What nurses really want: sufficient staffing for patient care

After gene therapy, two congenitally deaf children hear for the first time

hotspot

hotspot

leisure time

entertainment